UBS Group’s Vivos Therapeutics VVOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Buy |
142,801
+140,922
| +7,500% | +$445K | ﹤0.01% | 4922 |
|
|
2025
Q1 | $5.36K | Buy |
1,879
+1,490
| +383% | +$4.25K | ﹤0.01% | 7692 |
|
|
2024
Q4 | $1.67K | Buy |
389
+311
| +399% | +$1.33K | ﹤0.01% | 7938 |
|
|
2024
Q3 | $204 | Buy |
+78
| New | +$204 | ﹤0.01% | 7855 |
|
|
2023
Q4 | – | Sell |
-9,257
| Closed | -$1.78K | – | 8595 |
|
|
2023
Q3 | $1.78K | Buy |
+9,257
| New | +$1.78K | ﹤0.01% | 6687 |
|
|
2023
Q1 | – | Sell |
-18,812
| Closed | -$7.53K | – | 9070 |
|
|
2022
Q4 | $7.53K | Buy |
18,812
+9,149
| +95% | +$3.66K | ﹤0.01% | 7694 |
|
|
2022
Q3 | $6K | Buy |
9,663
+7,450
| +337% | +$4.63K | ﹤0.01% | 7966 |
|
|
2022
Q2 | $3K | Buy |
+2,213
| New | +$3K | ﹤0.01% | 8332 |
|
|
2022
Q1 | – | Sell |
-17,083
| Closed | -$38K | – | 9658 |
|
|
2021
Q4 | $38K | Buy |
17,083
+14,188
| +490% | +$31.6K | ﹤0.01% | 6071 |
|
|
2021
Q3 | $12K | Buy |
2,895
+555
| +24% | +$2.3K | ﹤0.01% | 6648 |
|
|
2021
Q2 | $12K | Buy |
2,340
+222
| +10% | +$1.14K | ﹤0.01% | 6803 |
|
|
2021
Q1 | $14K | Buy |
+2,118
| New | +$14K | ﹤0.01% | 6658 |
|